News

Deal Announcements

Altheos Adds To Series A Venture Capital Funding

Friday, February 10, 2012 5:34:00 AM PDT | VentureDeal Staff

   South San Francisco, California  --  Pharmaceutical company Altheos has added $12.5 million to its first institutional venture capital financing round.

Altheos is developing a next-generation eye drop treatment for glaucoma.

The company said it would use the financing to advance its lead candidate to phase 3 trials.

Bay City Capital, Canaan Partners, Novo A/S and others invested in the round.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.